Home › Alexion Pharmaceuticals, Inc. (ALXN) Position Decreased by EQIS Capital Management
 

Keywords :   


Alexion Pharmaceuticals, Inc. (ALXN) Position Decreased by EQIS Capital Management

2016-01-11 06:07:38| Biotech - Topix.net

EQIS Capital Management decreased its stake in Alexion Pharmaceuticals, Inc. by 51.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 9,974 shares of the biopharmaceutical company's stock after selling 10,740 shares during the period.

Tags: management position capital decreased

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
14.06Atlantic Tropical Weather Outlook
14.06Eastern North Pacific Tropical Weather Outlook
14.06The battle for Gen Z social shoppers
14.06JLR invests 1m to help police stop car thefts
13.06Bank fires employees over fake keyboard activity
13.06Eastern North Pacific Tropical Weather Outlook
13.06Atlantic Tropical Weather Outlook
13.06PCI Announces 2024 Scholarship Recipients
More »